3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Phase 2/3
1
Status
Completed
2
Unknown
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Pulmonary Embolism
1
Multiple Myeloma
1
Lymphoma
1
Leukemia
1
Hematologic Neoplasms
1
Interventions
Blood Specimen Collection
104
Standard of Care
79
Exercise
67
Radiotherapy
53
Radiosurgery
48
Specimen Handling
45
Magnetic Resonance Spectroscopy
45
Surveys and Questionnaires
44
Interviews as Topic
44
Practice Guidelines as Topic
43
Educational Status
43
Methods
41
Drug Therapy
35
Early Intervention, Educational
30
Surgical Procedures, Operative
29
Palliative Care
25
Control Groups
25
Biopsy
24
Patient Navigation
18
venetoclax
17
Cisplatin
17
Therapeutics
16
Resistance Training
16
Proton Therapy
15
Magnetic Resonance Imaging
15
Behavior Therapy
15
Neoadjuvant Therapy
13
Cognitive Behavioral Therapy
13
Acupuncture Therapy
13
Nutritional Status
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Recruiting
×
Rivaroxaban
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled